SGMO icon

Sangamo Therapeutics
SGMO

Overview Fund Activity

208 hedge funds and large institutions have $1.09B invested in Sangamo Therapeutics in 2018 Q1 according to their latest regulatory filings, with 57 funds opening new positions, 54 increasing their positions, 73 reducing their positions, and 17 closing their positions.

Holders
208
Holders Change
+38
Holders Change %
+22.35%
% of All Funds
4.77%
Holding in Top 10
5
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-16.67%
% of All Funds
0.11%
New
57
Increased
54
Reduced
73
Closed
17
Calls
$18.4M
Puts
$29.3M
Net Calls
-$10.9M
Net Calls Change
-$20.6M

Top Buyers

1
Vanguard Group
1
Vanguard Group
Pennsylvania
$132M
2
CS
2
Credit Suisse
Switzerland
$36.8M
3
Morgan Stanley
3
Morgan Stanley
New York
$23.6M
4
UBS AM
4
UBS AM
Illinois
$11.8M
5
State Street
5
State Street
Massachusetts
$86.2M

Top Sellers

1
CCS
1
Crosspoint Capital Strategies
California
$0
2
Fidelity Investments
2
Fidelity Investments
Massachusetts
$80.8M
3
D.E. Shaw & Co
3
D.E. Shaw & Co
New York
$6.27M
4
WA
4
Wasatch Advisors
Utah
$70.2M
5
BIM
5
Bogle Investment Management
Massachusetts
$1.26M
Name Market Value Shares Shares
Change 		Shares
Change %
ACP
226
Acuta Capital Partners
California
– – – –
ID
227
Integral Derivatives
New York
– – – –
6 7 8 9
10